-
Jun 01 |
Diagnostics World | Using a special tissue grinder, label-free cytometry, and machine learning, researchers in Germany have come up with a way to evaluate potentially cancerous tissue without a trained human pathologist in only 30 minutes—fast enough to be done during surgery.
More
-
May 30 |
Diagnostics World | NIH funding for at-home test distinguishing COVID, Flu, and RSV; card enables at-home blood sampling with analysis by mail; rapid diagnostics for antibiotic susceptibility; more.
More
-
May 24 |
Diagnostics World | AI in diagnostics partnerships from Cardio Diagnostics Holdings, Paige, and Visiopharm; Quest makes RestoreU Dementia Panal nationally available; Spanish groups release prognosis calculator for multiple myeloma. Plus: new products from Thermo Scientific, Aetion, Gyros Protein Technologies, and more.
More
-
May 18 |
Diagnostics World | A new antimicrobial susceptibility testing (AST) method developed by scientists at the University of California, Santa Barbara, resolves the longstanding conflict between what the gold-standard assay says will work and actual patient outcomes when it comes to selecting antibiotics. The alternative AST protocol reveals that antibiotics already widely available on the market can cure superbugs.
More
-
May 16 |
Diagnostics World News | In a first-of-its-kind, blinded and randomized clinical trial of artificial intelligence (AI) in cardiology, investigators at Cedars-Sinai Medical Center have shown that an “AI assistant” for assessing heart health works even better than sonographers at reading echocardiograms. The software was integrated with the institution’s picture archiving and communication system that securely stores and digitally transmits electronic images.
More
-
May 10 |
Diagnostics World | Researchers in Sweden who previously introduced a hydrogel wound dressing constructed of nanocellulose that requires no changing have further improved on their innovation with the integration of a pH sensor to passively monitor for early signs of infection. In parallel, they’re working on antimicrobial substances based on lipopeptides that are showing potency against multiple types of bacteria.
More
-
May 09 |
Diagnostics World | Whereas some detection and diagnosis tools search for mutations in certain genes or analyze the genome, an international group of researchers spanning Canada, the UK, and Australia has created an atlas of pediatric cancer using a machine-learning algorithm that considers the whole transcriptome.
More
-
May 05 |
Diagnostics World News | Next-generation sequencing (NGS) has revolutionized molecular biology and served as a universal tool for many research avenues across the spectrum of biology. With the NGS market expanding, three key barriers—time, cost, and expertise—are holding back the potential of NGS and the full impact it could have on society, diagnostics, and precision medicine.
More
-
May 04 |
Diagnostics World News | The first-ever wearable sensor for monitoring muscle atrophy has been developed by researchers at The Ohio State University thanks to an interest in the muscle-shrinking condition by NASA, which has been funding most of the work to date.
More
-
May 02 |
Diagnostics World News | Researchers at Pennsylvania State University are leading the development of a lateral flow assay for mpox (monkeypox), which in another few years could join pregnancy tests on retail pharmacy shelves. The more immediate plan is to produce a rapid, point-of-care (POC) test for low-resource settings that involves a smartphone or other small reader capable of differentiating mpox from smallpox based on the light bouncing back from gold nanoparticles underpinning the platform.
More
-
Sep 25 |
PRINCETON, NJ - Sep 25, 2019 - Certara®, the global model-informed drug development and decision support leader, today announced that the US Food and Drug Administration (FDA) has renewed its legacy licenses for Synchrogenixs electronic Common Technical Document (eCTD) review software, GlobalSubmit REVIEW and GlobalSubmit VALIDATE for another year
More
-
Sep 24 |
PHILADELPHIA, PA, UNITED STATES - Sep 24, 2019 - Proscia, a leading provider of digital pathology software, has been granted U.S. Patent No. 10,346,980 by the United States Patent and Trademark Office (USPTO)
More
-
Sep 24 |
ROYSTON, UK - Sep 24, 2019 - BioIVT, a leading provider of research models and services for drug and diagnostic development, today announced that it has joined UK Medicines Discovery Catapults Discovery Services Platform, partnering with other best-in-class service providers to help improve preclinical drug discovery success rates
More
-
Sep 17 |
, UK - Sep 17, 2019 - QuantuMDx Group Limited, a UK-based life sciences company developing transformational point of care diagnostics, is pleased to announce Neil Butler has joined its Board as an Independent Non-Executive Director
More
-
Sep 17 |
PRINCETON, NJ - Sep 17, 2019 - The WIRB-Copernicus Group®s (WCG) Clinical Services Division is pleased to announce that enrollment in WCG KMR Groups 2019 Clinical Trial Cost Study is now open
More
-
Sep 17 |
PRINCETON, NJ - Sep 17, 2019 - Certara®, the global model-informed drug development and decision support leader, today announced the launch of Hasharc, its decentralized application (DApp) for healthcare, built in conjunction with the Hedera public Distributed Ledger Technology (DLT)
More
-
Sep 12 |
HONOLULU, HI, UNITED STATES - Sep 13, 2019 - Honolulu, HI (September 13, 2019) - A recently released workforce supply and demand study conducted by the Healthcare Association of Hawaii (HAH) reveals a need for phlebotomists in the state
More
-
Sep 12 |
CAMBRIDGE, MA - Sep 12, 2019 - Shimmer Research, a global leader in wearable technology for research applications, today announced the launch of a healthcare industry open source initiative for wearable sensor algorithms
More
-
Sep 12 |
PRINCETON, NJ - Sep 12, 2019 - Certara®, the global model-informed drug development and decision support leader, today announced the launch of Phoenix® 8
More
-
Sep 11 |
ROYAL OAK, MI, UNITED STATES - Sep 11, 2019 - OncoCell MDx, Inc., a pan-disease immunogenomics platform company developing novel noninvasive blood-based tests to optimize patient care, today announced it has raised $22
More
View more articles